Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model
Felicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp · 2025
Read Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model by Felicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12827954.txt.
Description
Felicia Spitzer and co-authors present a new mouse model of dysfunctional CD4 T cells, in a 2025 paper. T cell exhaustion is implicated in cancer and chronic infections alike. Their model, named MolT-II, gives the T cells a built-in receptor tuned to a peptide from a Moloney virus coat protein. The cells can thus be tracked and triggered with precision in a living animal.
The model's CD4 cells prove dysfunctional: weak effector function, poor growth, and high levels of braking receptors on their surface. The likely cause is chronic exposure to a self-antigen. A peptide vaccine combined with checkpoint blockade restores their function in the animal, with better tumor control. The strain offers a reversible test bed for studying CD4 regulation.
Catalog record
| CREATOR | Felicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |